Design, synthesis and neuroprotective potency of self‐assembling memantine‐docosahexaenoic acid conjugate nanomedicine for the effective treatment of Alzheimer’s disease Nonhuman/Target identification and validation studies: Cognitive enhancement and other behavioral symptoms
Abstract Background Alzheimer’s Disease (AD) is the most common type of dementia characterized with progressive neurodegeneration and seems to be irreversible, progressive and presently untreatable. Memantine (MEM), a N‐methyl‐D‐aspartate receptor antagonist has been approved by FDA for symptomatic...
Saved in:
Published in | Alzheimer's & dementia Vol. 16; no. S9 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
01.12.2020
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background
Alzheimer’s Disease (AD) is the most common type of dementia characterized with progressive neurodegeneration and seems to be irreversible, progressive and presently untreatable. Memantine (MEM), a N‐methyl‐D‐aspartate receptor antagonist has been approved by FDA for symptomatic relief in neurodegenerative disorders. Docosahexaenoic acid (DHA) is a brain essential omega‐3 fatty acid that has a vital role in functional development and growth of the brain in infants. It has been reported that the presence of DHA in the diet helps in cognitive enhancement. Hypothesizing the co‐delivery of MEM and DHA for the effective treatment of AD, herein our aim was to design and develop a novel self‐assembling MEM‐DHA conjugate nanomedicine and to investigate its neuroprotective potency on SH‐SY5Y cells. Furthermore, the efficacy of these nanoparticles was assessed in intracerebroventricular‐β‐amyloid
1‐42
induced cognitive deficits rats. To the best of our knowledge, this is the first report on self‐assembling nanomedicine of MEM.
Method
MEM‐DHA was synthesized by amide coupling reaction and thoroughly characterized by
1
H NMR,
13
C NMR and HR‐MS. The synthesized conjugate was self‐assembled into nanoparticles by using nanoprecipitation method and morphological characterization was performed by using dynamic light scattering technique and by FE‐SEM analysis. The neuroprotective activity was performed on human neuroblastoma SH‐SY5Y cells against oxidative stress induced by H
2
O
2
. Animals were injected with β‐amyloid
1‐42
through intracerebroventricular route and dosage administered for a period of 28 days in separate groups viz control, disease control, MEM, MEM‐DHA conjugate and MEM‐DHA nanoparticles. Learning, behavior, memory assessment and biochemical parameters were estimated.
Result
The formation of MEM‐DHA conjugate was confirmed by
1
H NMR,
13
C NMR and HR‐MS. MEM‐DHA conjugate has a property to self‐assemble into nanoparticles due to its amphiphilic nature. The average hydrodynamic size of the self‐assembled nanoparticles was found to be 144.30 ± 3.91 nm with a polydispersity index 0.181 ± 0.02 and zeta potential was ‐6.82 ± 0.51 (Fig.1.). Cell culture and animal studies revealed MEM‐DHA conjugate nanoparticles are having strong potential as a therapeutic delivery to restore memory impairment in AD.
Conclusion
The MEM‐DHA conjugate nanomedicine was successfully prepared, thoroughly characterized and has shown improved neuroprotective efficacy in cognitive induced rats. |
---|---|
AbstractList | Abstract
Background
Alzheimer’s Disease (AD) is the most common type of dementia characterized with progressive neurodegeneration and seems to be irreversible, progressive and presently untreatable. Memantine (MEM), a N‐methyl‐D‐aspartate receptor antagonist has been approved by FDA for symptomatic relief in neurodegenerative disorders. Docosahexaenoic acid (DHA) is a brain essential omega‐3 fatty acid that has a vital role in functional development and growth of the brain in infants. It has been reported that the presence of DHA in the diet helps in cognitive enhancement. Hypothesizing the co‐delivery of MEM and DHA for the effective treatment of AD, herein our aim was to design and develop a novel self‐assembling MEM‐DHA conjugate nanomedicine and to investigate its neuroprotective potency on SH‐SY5Y cells. Furthermore, the efficacy of these nanoparticles was assessed in intracerebroventricular‐β‐amyloid
1‐42
induced cognitive deficits rats. To the best of our knowledge, this is the first report on self‐assembling nanomedicine of MEM.
Method
MEM‐DHA was synthesized by amide coupling reaction and thoroughly characterized by
1
H NMR,
13
C NMR and HR‐MS. The synthesized conjugate was self‐assembled into nanoparticles by using nanoprecipitation method and morphological characterization was performed by using dynamic light scattering technique and by FE‐SEM analysis. The neuroprotective activity was performed on human neuroblastoma SH‐SY5Y cells against oxidative stress induced by H
2
O
2
. Animals were injected with β‐amyloid
1‐42
through intracerebroventricular route and dosage administered for a period of 28 days in separate groups viz control, disease control, MEM, MEM‐DHA conjugate and MEM‐DHA nanoparticles. Learning, behavior, memory assessment and biochemical parameters were estimated.
Result
The formation of MEM‐DHA conjugate was confirmed by
1
H NMR,
13
C NMR and HR‐MS. MEM‐DHA conjugate has a property to self‐assemble into nanoparticles due to its amphiphilic nature. The average hydrodynamic size of the self‐assembled nanoparticles was found to be 144.30 ± 3.91 nm with a polydispersity index 0.181 ± 0.02 and zeta potential was ‐6.82 ± 0.51 (Fig.1.). Cell culture and animal studies revealed MEM‐DHA conjugate nanoparticles are having strong potential as a therapeutic delivery to restore memory impairment in AD.
Conclusion
The MEM‐DHA conjugate nanomedicine was successfully prepared, thoroughly characterized and has shown improved neuroprotective efficacy in cognitive induced rats. |
Author | Krishna, Kowthavarapu Venkata Saha, Ranendra Narayan Dubey, Sunil Kumar |
Author_xml | – sequence: 1 givenname: Kowthavarapu Venkata surname: Krishna fullname: Krishna, Kowthavarapu Venkata organization: Birla Institute of Technlogy and Science, Pilani Pilani India – sequence: 2 givenname: Sunil Kumar surname: Dubey fullname: Dubey, Sunil Kumar organization: Birla Institute of Technlogy and Science, Pilani Pilani India – sequence: 3 givenname: Ranendra Narayan surname: Saha fullname: Saha, Ranendra Narayan organization: Birla Institute of Technology and Science Pilani Dubai United Arab Emirates |
BookMark | eNqVkE1OwzAQRi1UJFpgwwlmjWhxmoSfJQIqDsA-Gpxx6ioeRx4Xka56BLacgjv1JKSiYs9qnkaf9KQ3USMOTEpdZHqWaT2_xnYz00Ve6PxIjbOynE_L-e396I9v9ImaiKy0LvRdVo7V9xOJa_gKpOe0HFgAuQamdQxdDIlMcu8E3UBseggWhFq7236iCPm31nEDnjxyckzDuw4mCC7pA4mDM4DG1WACr9YNJgJGDp5qZ4Y12BBhcAJZe9CkSJg8cdqLHtrNkpynuNt-CdROCIXO1LHFVuj8cE_V5eL59fFlamIQiWSrLjqPsa8yXe2TVEOS6jdJ_q_xD4G3csY |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1002/alz.043403 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1552-5279 |
ExternalDocumentID | 10_1002_alz_043403 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1OC 1~. 1~5 24P 33P 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 8FI 8FJ 8P~ AACTN AAEDT AAHHS AAIKJ AAKOC AALRI AANLZ AAOAW AAXLA AAXUO AAYXX ABBQC ABCQJ ABCUV ABIVO ABJNI ABMAC ABMZM ABUWG ACCFJ ACCZN ACGFS ACGOF ACPOU ACXQS ADBBV ADBTR ADEZE ADHUB ADKYN ADMUD ADPDF ADVLN ADZMN ADZOD AEEZP AEIGN AEKER AENEX AEQDE AEUYR AEVXI AFKRA AFTJW AGHFR AGUBO AGWIK AGYEJ AITUG AIURR AIWBW AJBDE AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS ALUQN AMFUW AMRAJ AMYDB ANZVX AZQEC BENPR BFHJK BLXMC C45 CCPQU CITATION DCZOG EBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYUFA G-Q GBLVA HMCUK HVGLF HX~ HZ~ IHE J1W K9- LATKE LEEKS M0R M41 MO0 MOBAO N9A NAPCQ O-L O9- OAUVE OVD OVEED OZT P-8 P-9 P2P PC. PGMZT PIMPY PSYQQ Q38 QTD RIG ROL RPM RPZ SDF SDG SEL SES SSZ SUPJJ T5K TEORI UKHRP ~G- |
ID | FETCH-crossref_primary_10_1002_alz_0434033 |
ISSN | 1552-5260 |
IngestDate | Fri Aug 23 03:34:58 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S9 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1002_alz_0434033 |
ParticipantIDs | crossref_primary_10_1002_alz_043403 |
PublicationCentury | 2000 |
PublicationDate | 2020-12-00 |
PublicationDateYYYYMMDD | 2020-12-01 |
PublicationDate_xml | – month: 12 year: 2020 text: 2020-12-00 |
PublicationDecade | 2020 |
PublicationTitle | Alzheimer's & dementia |
PublicationYear | 2020 |
SSID | ssj0040815 |
Score | 4.637245 |
Snippet | Abstract
Background
Alzheimer’s Disease (AD) is the most common type of dementia characterized with progressive neurodegeneration and seems to be irreversible,... |
SourceID | crossref |
SourceType | Aggregation Database |
Subtitle | Nonhuman/Target identification and validation studies: Cognitive enhancement and other behavioral symptoms |
Title | Design, synthesis and neuroprotective potency of self‐assembling memantine‐docosahexaenoic acid conjugate nanomedicine for the effective treatment of Alzheimer’s disease |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELZK98IFgQDxL0tworSExu02R8QWrZAACZbV3qqJM1W7tE7VJMD2tI_AlafgXXiEfRJmYscJZQ-FSxQ5iZ1kvngmM9-MhXjC0UUItaYvTcddlURhN9aB6kIcKCQNqhJkf8fbd8PDT-rNyeCk1frVYC0VedzTm0vzSv5HqtRGcuUs2X-QrO-UGmif5EtbkjBtd5LxQUm_4LeUnRmy5Li4CDvCyyKVrgIDM4NWaV5mWJJhmOFi6gkOZDjjMi4T0pe4BF40Av3BJNVpBjP8BmhSruqq55wBZ04L9rx1DJi0Csx7rqJlh_CQNYGdTd3FZoZzXqfFdR5lf0SGqiq4_jQOIjAmk9J5Ofeqg6ekmctiS7_mM_gCa1gVnWM0n22SnbPKY8dhK8x80Slp5N6VBDbE9QEMmmQNpF_WcOa-Eef-6DepJG7GHvDftF2UoIfNNrtKjZ_mhw04f4wuVR-2HC0sNr1AhSoIayVZEQO2dKdnNNrqz_0JXTux114Re3QHg_222Ht_PB4fVPaBIiNsUFbxdTfui-b2n9cjN8ykhr1zdF1ccz8q8qVF3Q3RQnNT_LSIeyY93iThTW7hTTq8yXQqGW8X599rpEmPNGrewphkjEmPMdnEmCSMSRpTeoxJjzEeyIPn4vxHJh26bomnr8dHrw671VNOVra6yuTvNxneFm2TGrwj5L4aJcPkhQbAkUqUjlBBHEGAiFM9GuFd8XiHDu_tdNZ9cbUG3APRztcFPiQLNI8fOZH-BmjpmlY |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Ovid |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design%2C+synthesis+and+neuroprotective+potency+of+self%E2%80%90assembling+memantine%E2%80%90docosahexaenoic+acid+conjugate+nanomedicine+for+the+effective+treatment+of+Alzheimer%E2%80%99s+disease&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=Krishna%2C+Kowthavarapu+Venkata&rft.au=Dubey%2C+Sunil+Kumar&rft.au=Saha%2C+Ranendra+Narayan&rft.date=2020-12-01&rft.issn=1552-5260&rft.eissn=1552-5279&rft.volume=16&rft.issue=S9&rft_id=info:doi/10.1002%2Falz.043403&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_alz_043403 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5260&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5260&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5260&client=summon |